Liquid biopsy using extracellular vesicular DNA for EGFR mutation testing in the patients with NSCLC

被引：0
|
作者：
Hur, Jae Young
Kim, Hee Jung
Choi, Chang-Min
Lee, Jae Cheol
Lee, Kye Young
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2748
引用
收藏
页数：2
相关论文
共 50 条
  • [31] DISPARITIES IN ACCESS TO EGFR-MUTATION TESTING IN PATIENTS WITH ADVANCED NSCLC IN GERMANY 2011
    Kellermann, L.
    Ukena, D.
    VALUE IN HEALTH, 2012, 15 (07) : A360 - A361
  • [32] EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC
    Roland Penzel
    Christine Sers
    Yuan Chen
    Ulrich Lehmann-Mühlenhoff
    Sabine Merkelbach-Bruse
    Andreas Jung
    Thomas Kirchner
    Reinhard Büttner
    Hans H. Kreipe
    Iver Petersen
    Manfred Dietel
    Peter Schirmacher
    Virchows Archiv, 2011, 458 : 95 - 98
  • [33] Comparison of Maintenance Therapy in EGFR Mutation Negative and EGFR Mutation Positive NSCLC Patients
    Joshi, Amit
    Noronha, Vanita
    Mahajan, Abhishek
    Janu, Amit
    Chougule, Anuradha
    Jambhekar, Nirmala
    Kumar, Rajeev
    Prabhash, Kumar
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S763 - S763
  • [34] EGFR Mutation Testing and First Line Treatment of Patients With Advanced NSCLC and Positive EGFR Mutation Status - Results From a German Registry
    Eberhardt, W.
    Thomas, M.
    von der Schulenburg, J. M. Graf
    Dietel, M.
    Schirmacher, P.
    Gutendorf, B.
    Zirrgiebel, U.
    Schuette, W.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S636 - S636
  • [35] Feasibility of liquid biopsy using extracellular vesicle-derived DNA isolated from bronchoalveolar lavage fluid and plasma in addition to tissue rebiopsy to detect T790M mutation in NSCLC patients with acquired resistance to EGFR-TKIs
    Lee, Jong Sik
    Kim, Hee Joung
    Kim, In Ae
    Hur, Jae Young
    Lee, Kye Young
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Retreatment with EGFR-TKI for 541 NSCLC Patients with EGFR Mutation
    Takahashi, K.
    Ito, K.
    Murotani, K.
    Asada, K.
    Okuno, M.
    Kimura, T.
    Kubo, A.
    Suda, T.
    Taniguchi, H.
    Hataji, O.
    Shindo, J.
    Kunii, E.
    Yoshida, T.
    Imaizumi, K.
    Hida, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S833 - S833
  • [37] The Usefulness of Liquid Biopsy for ctDNA in Patients with EGFR-Mutant NSCLC During and After Treatment with EGFR-TKIs
    Yokoyama, T.
    Naka, G.
    Ishida, H.
    Kishi, K.
    Ohashi, Y.
    Kunitoh, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2223 - S2223
  • [38] The Monitoring of Mutated EGFR Levels in Liquid Biopsy from Patients on EGFR-TKIs - Early Detection of NSCLC Progression
    Szpechcinski, A.
    Bryl, M.
    Czyzewicz, G.
    Wojda, E.
    Szwiec, M.
    Swiniuch, D.
    Rudzinski, S.
    Duk, K.
    Ramlau, R.
    Sliwinski, P.
    Barinow-Wojewodzki, A.
    Chorostowska-Wynimko, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S421 - S421
  • [39] EGFR mutation detection in NSCLC-assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC
    Penzel, Roland
    Sers, Christine
    Chen, Yuan
    Lehmann-Muehlenhoff, Ulrich
    Merkelbach-Bruse, Sabine
    Jung, Andreas
    Kirchner, Thomas
    Buettner, Reinhard
    Kreipe, Hans H.
    Petersen, Iver
    Dietel, Manfred
    Schirmacher, Peter
    VIRCHOWS ARCHIV, 2011, 458 (01) : 95 - 98
  • [40] EGFR MUTATION IN AUSTRIAN PATIENTS WITH NSCLC: A RETROSPECTIVE STUDY
    Hochmair, M. J.
    Miler, M.
    Setinek, U.
    Kirchbacher, K.
    Mohn-Staudner, A.
    Kaufmann, M.
    Kapfhammer, I.
    Arns, M. B.
    Patocka, K.
    Burghuber, O. C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S66 - S66
12345